EX-15.1 2 exhibit151-2017q2.htm EXHIBIT 15.1 Exhibit


Exhibit 15.1


May 9, 2017


Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549


Commissioners:

We are aware that our report dated May 9, 2017 on our review of interim financial information of Varian Medical Systems, Inc. for the three and six month periods ended March 31, 2017 and April 1, 2016 and included in the Company's quarterly report on Form 10-Q for the quarter ended March 31, 2017 is incorporated by reference in its Registration Statements on Form S‑8 (No.333-188693, No.333-168444, No. 333-168443, No. 333-146176, No. 333-130001, No. 333-152903, No. 333-123778, No. 333-75531, No. 333-57006, No. 333-57008, No. 333-57010, and No. 333-161307).


Very truly yours,


/S/ PRICEWATERHOUSECOOPERS LLP
PricewaterhouseCoopers LLP


PricewaterhouseCoopers LLP, 488 Almaden Boulevard, Suite 1800, San Jose, CA 95110
T: (408) 817 3700, F: (408) 817 5050, www.pwc.com/us